Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein

Circulation Research
L J IgnarroG Frank

Abstract

The objective of this study was to elucidate the mechanism by which polyamino acids containing L-arginine, L-lysine or L-ornithine cause endothelium-dependent relaxation of bovine intrapulmonary artery and vein. Basic but not acidic or neutral polypeptides ranging in average molecular weights from 17 to 225 kDa elicited time- and concentration-dependent relaxation and cyclic GMP accumulation in precontracted rings of artery and vein by endothelium-dependent mechanisms. Vascular responses were markedly inhibited by oxyhemoglobin, methylene blue, or potassium. The basic polyamino acids stimulated the formation and/or release of an endothelium-derived relaxing factor (EDRF) identified as nitric oxide (NO) in perfused segments of both artery and vein as assessed by bioassay. The polyamino acids and A23187 released a similar endothelium-derived NO (EDNO) from artery and vein, as assessed by the similar half-life (3-5 seconds), antagonism by superoxide anion or oxyhemoglobin, enhancement by superoxide dismutase, and lack of influence by indomethacin. The basic polyamino acids elicited potent relaxant responses with EC50 values ranging from 3 x 10(-9) to 2 x 10(-7) M, and a direct correlation was obtained between molecular weight and ...Continue Reading

References

Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G de NucciJ R Vane
Feb 26, 1985·European Journal of Pharmacology·P Schoeffter, J C Stoclet
Apr 2, 1986·European Journal of Pharmacology·C A Gruetter, S M Lemke
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S MoncadaR J Gryglewski
Apr 27, 1988·European Journal of Pharmacology·L J IgnarroG Chaudhuri
Dec 15, 1986·Biochemical and Biophysical Research Communications·G ThomasP W Ramwell
Aug 7, 1985·European Journal of Pharmacology·P D'Orléans-JusteD Regoli
Mar 12, 1982·European Journal of Pharmacology·S P Duckles, S I Said
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R J WinquistR M Rapoport
Jan 1, 1984·Annual Review of Pharmacology and Toxicology·R F Furchgott
Nov 1, 1984·Circulation Research·Z S KatusicP M Vanhoutte
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P D CherryD Jothianandan
Oct 1, 1964·British Journal of Pharmacology and Chemotherapy·J R VANE

❮ Previous
Next ❯

Citations

Nov 29, 2001·British Journal of Pharmacology·K MuraseM Sokabe
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K NakazonoM Inoue
Oct 29, 1998·Mediators of Inflammation·V A VincentA M Van Dam
Apr 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H Kinoshita, Z S Katusic
Jul 1, 1995·Acta Anaesthesiologica Scandinavica·T AkataS Takahashi
Dec 1, 1990·British Journal of Pharmacology·E AntunesG de Nucci
Aug 1, 1993·British Journal of Pharmacology·T AkataS Takahashi
Nov 1, 1989·The Journal of Clinical Investigation·B M BrennerB J Ballermann
Feb 28, 2002·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toshio Nakaki, Keiichi Hishikawa
Jun 1, 1995·Annals of Medicine·I Paakkari, P Lindsberg
Sep 15, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Michael K PugsleyMichael J Curtis
Aug 1, 1995·The Annals of Thoracic Surgery·P R EvoraH V Schaff
Oct 1, 1993·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S Hyslop, G De Nucci
Feb 1, 1991·Journal of Cardiothoracic and Vascular Anesthesia·R A Johns
May 26, 2016·Expert Opinion on Drug Metabolism & Toxicology·Emilia SokolowskaAndrzej Mogielnicki
Dec 22, 1999·Journal of Cardiovascular Pharmacology·L J IgnarroC Napoli
Mar 3, 2020·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Toshio Hayashi
Jul 16, 1990·Biochemical and Biophysical Research Communications·K S WoodL J Ignarro
Sep 1, 1991·Chest·J S BagleyG L Blackburn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.